BlueRock Therapeutics — Biomedical Watch V2

Traitements3programmes

Essais1liés

Publications4liées

SourceDBlocale

Traitements

3

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
bemdaneprocelStudy BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).	Parkinson	Phase 3	À vérifier	United States, Australia, Canada	À vérifier
Sham surgeryStudy BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).	Parkinson	Phase 3	À vérifier	United States, Australia, Canada	À vérifier
bemdaneprocelStudy BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).	Parkinson	Phase 3	À vérifier	United States, Australia, Canada	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
bemdaneprocel	Parkinson	Phase 3	NCT06944522	exPDite-2 — A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease	RECRUITING

Publications

4

Molécule	Indication / population	Titre	Journal	Date
Sham surgery		Endolymphatic duct blockage for Ménière's disease: a double-blind, randomised controlled trial.	The Lancet regional health. Europe
Sham surgery		Reduced myocardial NRG-1/ErbB4 signaling is associated with STING-linked macrophage pyroptotic signaling in sepsis-induced cardiac injury.	International immunopharmacology
Sham surgery		Combined environmental enrichment and aerobic exercise improve cognitive recovery in male rats after bilateral common carotid artery occlusion.	Physiology & behavior
bemdaneprocel		Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease.	Nature